The study was supported by the UTSW Clinical and Translational Science Award, the National Institutes of Health (1U54TR00236), the Texas Health Resource Clinical Scholar program, and the UTSW Nutrition & Obesity Research Center (NORC)
We hear about their challenges, their victories, and the small logistical hurdles that can make or break a health journey
Warning signs requiring prompt evaluation include: Rectal bleeding or blood in stool Unexplained weight loss (beyond expected medication effect) Persistent change in bowel habits lasting more than a few weeks New-onset abdominal pain that differs from typical GLP-1 side effects Iron-deficiency anemia These symptoms warrant investigation regardless of medication use, as they may indicate various gastrointestinal conditions requiring diagnosis
Once Mendosa started the injections, he began to feel fuller after meals, curbing his appetite and leading to his eating smaller portions and fewer unnecessary snacks
Preliminary studies have suggested that GLP-1 drugs might protect against or treat dementia and Alzheimers disease
This means liraglutide reaches steady-state concentrations within 3 to 5 days, whereas semaglutide requires 4 to 5 weeks
&srotate=0)
